Tag: CRT

JenaValve’s Trilogy THV System Highlighted at CRT 2024

Coronary/Structural Heart by Comments are Disabled

IRVINE, Calif., March 19, 2024 (GLOBE NEWSWIRE) — JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced highlights from the Cardiovascular Research Technologies (CRT) Conference 2024. JenaValve’s Trilogy THV system, a TAVR system designed to treat patients with symptomatic, severe aortic regurgitation (ssAR), and symptomatic, severe aortic stenosis (ssAS), was featured in multiple scientific sessions highlighting the significant unmet need for devices to treat ssAR.

Continue Reading →

New late-breaking data from Medtronic Evolut™ Low Risk Trial demonstrate strong clinical and cost-effectiveness benefits of TAVR platform

Coronary/Structural Heart by 0 comments

CRT 2024: Evolut TAVR is a safe, effective, and economically cost-effective treatment option for low-risk severe aortic stenosis patients compared to surgery up to four years   DUBLIN, March 11, 2024 — Medtronic plc, a global leader in healthcare technology, today announced two late-breaking data presentations on four-year outcomes from the Evolut™ Low Risk Trial. […]

Continue Reading →

4C Medical’s Novel Mitral Regurgitation Therapy to be Highlighted at CRT 2019 Meeting

Coronary/Structural Heart by 0 comments

BROOKLYN PARK, Minn., Feb. 25, 2019 /PRNewswire/ — 4C Medical Technologies, Inc. (4C Medical), a developer of minimally invasive technologies for structural heart disease, today announced that its AltaValve™, a transcatheter mitral valve replacement (TMVR) technology,  will be highlighted in the following presentations at the Cardiovascular Research Technologies (CRT) meeting held March 2-5, 2019 in Washington, DC. Sunday, March 3 @ 2:50pm during Percutaneous […]

Continue Reading →

Saranas’ Novel Bleed Monitoring System Receives Recognition in Cardiovascular Research Technologies 2018 Competition

Coronary/Structural Heart by 0 comments

HOUSTON–(BUSINESS WIRE)– Saranas, a medical device company with a cutting-edge technology for real-time detection and monitoring of internal bleeding during endovascular procedures, placed first runner-up at the Cardiovascular Research Technologies (CRT) competition on March 6, 2018, in Washington, D.C. “We are extremely honored that our Early Bird™ Bleed Monitoring System has been recognized as a top cardiovascular innovation […]

Continue Reading →

EBR Systems, Inc. Initiates Global Trial of World’s Only Wireless CRT Pacing Technology

Rhythm by 0 comments

SUNNYVALE, Calif.–(BUSINESS WIRE)–EBR Systems, Inc., developer of the world’s only wireless cardiac pacing system for heart failure, today announced enrollment of the first patients in the global SOLVE-CRT (Stimulation of the Left Ventricular Endocardium for Cardiac Resynchronization Therapy) clinical trial. The first patients were enrolled by Prof. Dr. Christian Butter at Immanuel Klinikum Herzzentrum Brandenburg […]

Continue Reading →

Fewer Leads, Fewer Complications: BIOTRONIK US Launches Proven DX Technology for Heart Failure Patients

Rhythm by 0 comments

LAKE OSWEGO, Ore., July 19, 2017 /PRNewswire/ — BIOTRONIK today announced FDA approval and availability of the Intica DX and Intica cardiac resynchronization therapy (CRT)-DX implantable cardioverter defibrillator (ICD) systems. The launch of Intica CRT-DX extends the proven benefits of BIOTRONIK’s DX technology to heart failure patients. DX eliminates the need for an atrial lead while still providing physicians […]

Continue Reading →

EBR Systems Awarded Favorite Innovation For Wise CRT At 2017 EHRA Europace Cardiostim Congress

Rhythm by 0 comments

SUNNYVALE, Calif.–(BUSINESS WIRE)–EBR Systems, Inc., developer of the world’s smallest, wireless, implantable device for cardiac pacing, today announced that WiSE CRT received the Favorite Innovation Award for its second-generation system at the 2017 EHRA Europace Cardiostim congress in Vienna, Austria. Cardiostim Innovation Awards are selected by an international panel of expert scientists and physicians from […]

Continue Reading →

Medtronic (MDT) Release: New Data Reveal Medtronic CRT Devices Improve Therapy Delivery And Reduce Healthcare Costs

Rhythm by 0 comments

DUBLIN and VIENNA – June 20, 2017 – Medtronic plc (NSYE: MDT) Medtronic Press Release: today announced new data showing that use of its cardiac resynchronization therapy (CRT) devices – with its proprietary AdaptivCRT(TM) and EffectiveCRT(TM) algorithms – results in lower healthcare system costs, and improves therapy delivery in heart failure patients who also have […]

Continue Reading →